Keyword: WIRB-Copernicus Group
UCSF scientist Shaun Coughlin will lead CV research at NIBR, Novo's China GM was promoted to EVP, and Cavion poached Teva exec to head up R&D.
WIRB-Copernicus Group has bought Patient Genesis’ eConsent technology, ConsentNow.
Scott Gottlieb was confirmed to lead FDA, neuroscientist Thomas Insel left Verily, Immunomedics' CEO and CSO stepped down.
WIRB-Copernicus Group continued an acquisition spree with purchases of electronic clinical outcome assessments specialists MedAvante and ProPhase.